Puma Biotechnology Inc (PBYI)
4.83
-0.30
(-5.85%)
USD |
NASDAQ |
Apr 24, 16:00
4.835
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Debt to Equity Ratio: 1.865 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.865 |
| September 30, 2023 | 2.563 |
| June 30, 2023 | 3.255 |
| March 31, 2023 | 3.816 |
| December 31, 2022 | 4.550 |
| September 30, 2022 | 4.423 |
| June 30, 2022 | 4.949 |
| March 31, 2022 | 13.63 |
| December 31, 2021 | -39.69 |
| September 30, 2021 | -8.863 |
| June 30, 2021 | 3.398 |
| March 31, 2021 | 6.035 |
| December 31, 2020 | -16.52 |
| Date | Value |
|---|---|
| September 30, 2020 | -215.07 |
| June 30, 2020 | 4.126 |
| March 31, 2020 | 10.21 |
| December 31, 2019 | 5.438 |
| September 30, 2019 | 5.482 |
| June 30, 2019 | 4.292 |
| March 31, 2019 | 3.516 |
| December 31, 2018 | 4.427 |
| September 30, 2018 | 2.637 |
| June 30, 2018 | 3.140 |
| March 31, 2018 | 0.8451 |
| December 31, 2017 | 0.9095 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-215.07
Minimum
Sep 2020
13.63
Maximum
Mar 2022
-10.64
Average
4.126
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| ADMA Biologics Inc | 0.9659 |
| Regeneron Pharmaceuticals Inc | 0.0763 |
| Sarepta Therapeutics Inc | 1.441 |
| CytomX Therapeutics Inc | 0.00 |
| Mirum Pharmaceuticals Inc | 1.232 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 230.53M |
| Total Liabilities (Quarterly) | 177.09M |
| Shareholders Equity (Quarterly) | 53.44M |
| Current Ratio | 1.572 |
| Net Debt Paydown Yield | -0.16% |